Summary:
Right now, patients are being enrolled in the APeX-S study, a worldwide clinical research study evaluating the safety and effectiveness of an investigational oral medication that may prevent hereditary angioedema (HAE) attacks.
If you have HAE, have regular attacks and are interested in learning about a potential alternative to injections or infusions to prevent attacks, we invite you to see if you qualify.
No health insurance or doctor referral is needed to participate.
Qualified Participants Must:
• Have been diagnosed with HAE Type 1 or 2
• Be 18 years or older
• Have regular HAE attacks
• Have access to and can be treated with medicine for HAE attacks
• Currently taking androgens to prevent HAE attacks ot have recently stopped taking androgens for prevention of attacks
Qualified Participants May Receive:
- Compensation for time and travel
- Study related care at no cost
- Study medication at no cost